Akonni Biosystems has received US Patent No 7,759,112 entitled, 'Apparatus, system, and method for purifying nucleic acids' that protects the company’s use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification from the USPTO.
Akonni said that TruTip Extraction Kits were released to the market last November and are the latest products by Akonni Biosystems to be protected by a US Patent.
TruTip Extractions Kits are also available for Eppendorf’s epMotion liquid handling systems when ultra-rapid, hands-free automation and sample throughput from 16 to 384 extractions per day is important.
Phil Belgrader, vice president of research and development at Akonni, said: “We believe the use of this methodology has the potential to change the health care industry and impact the identification and treatment of disease by reducing the time it takes to obtain PCR-ready material from clinical samples to just a few minutes.
“This methodology is available today in Akonni’s TruTip product line, where the more rapid extraction of nucleic acids is already accelerating the identification of influenza and cancer markers, speeding genetics research and drug discovery, and even helping solve forensics cases faster.”